Towards an HIV cure: a global scientific strategy (original) (raw)

• Phillips, A. N., Neaton, J. & Lundgren, J. D. The role of HIV in serious diseases other than AIDS. AIDS 22, 2409–2418 (2008).
  Article PubMed Google Scholar
• UN Secretary-General. Uniting for universal access: towards zero new HIV infections, zero discrimination and zero AIDS-related deaths (United Nations, 2011).
• Cohen M. S. et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365, 493–505 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Richman, D. D. et al. The challenge of finding a cure for HIV infection. Science 323, 1304–1307 (2009).
  Article CAS PubMed Google Scholar
• Trono, D. et al. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science 329, 174–180 (2010).
  Article CAS PubMed Google Scholar
• Cohen, J. The emerging race to cure HIV infections. Science 332, 784–789 (2011).
  Article CAS PubMed Google Scholar
• Siliciano, J. D. et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature Med. 9, 727–728 (2003).
  Article CAS PubMed Google Scholar
• Yukl, S. A. et al. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 24, 2451–2460 (2010).
  Article CAS PubMed Google Scholar
• Buzon, M. J. et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nature Med. 16, 460–465 (2010).
  Article PubMed Google Scholar
• Stebbing, J., Gazzard, B. & Douek, D. C. Where does HIV live? N. Engl. J. Med. 350, 1872–1880 (2004).
  Article CAS PubMed Google Scholar
• Wightman, F. et al. Both CD31+ and CD31− naive CD4+ T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy. J. Infect. Dis. 202, 1738–1748 (2010).
  Article PubMed Google Scholar
• Kitchen, S. G. & Zack, J. A. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J. Virol. 71, 6928–6934 (1997).
  CAS PubMed PubMed Central Google Scholar
• Carter, C. C. et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nature Med. 16, 446–451 (2010).
  Article CAS PubMed Google Scholar
• Churchill, M. J. et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 66, 253–258 (2009).
  Article PubMed Google Scholar
• Burke, B. et al. Primary cell model for activation-inducible human immunodeficiency virus. J. Virol. 81, 7424–7434 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Saleh, S. et al. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood 110, 4161–4164 (2007).
  Article CAS PubMed Google Scholar
• Swiggard, W. J. et al. Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J. Virol. 79, 14179–14188 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Bosque, A. & Planelles, V. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 113, 58–65 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Marini, A., Harper, J. M. & Romerio, F. An in vitro system to model the establishment and reactivation of HIV-1 latency. J. Immunol. 181, 7713–7720 (2008).
  Article CAS PubMed Google Scholar
• Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Siliciano, R. F. & Greene, W. C. HIV latency. Cold Spring Harb. Perspect. Med. 1, a007096 (2011).
  Article PubMed PubMed Central Google Scholar
• Sobhian, B. et al. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol. Cell 38, 439–451 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Della Chiara, G. et al. Negative regulation of HIV-1 transcription by a heterodimeric NF-κB1/p50 and C-terminally truncated STAT5 complex. J. Mol. Biol. 410, 933–943 (2011).
  Article CAS PubMed Google Scholar
• Tyagi, M., Pearson, R. J. & Karn, J. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J. Virol. 84, 6425–6437 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Williams, S. A. et al. NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25, 139–149 (2006).
  Article CAS PubMed Google Scholar
• Treand, C. et al. Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J. 25, 1690–1699 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Blazkova, J. et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 5, e1000554 (2009).
  Article PubMed PubMed Central Google Scholar
• Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V. & Verdin, E. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 5, e1000495 (2009).
  Article PubMed PubMed Central Google Scholar
• Van Lint, C., Emiliani, S., Ott, M. & Verdin, E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15, 1112–1120 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Han, Y. et al. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 4, 134–146 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nature Med. 15, 893–900 (2009).
  Article CAS PubMed Google Scholar
• Bosque, A. Famiglietti, M., Weyrich, A. S., Goulston, C. & Planelles, V. Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. PLoS Pathog. 7, e1002288 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lehrman, G. et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366, 549–555 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Xing, S. et al. Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. J. Virol. 85, 6060–6064 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Archin, N. M. et al. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retroviruses 25, 207–212 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Contreras, X. et al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J. Biol. Chem. 284, 6782–6789 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bouchat, S. et al. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1+ HAART-treated patients. AIDS 19 May 2012 (doi:10.1097/QAD.0b013e32835535f5).
  Article CAS PubMed Google Scholar
• Yukl, S. A. et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J. Infect. Dis. 202, 1553–1561 (2010).
  Article PubMed Google Scholar
• Deleage, C. et al. Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo. Am. J. Pathol. 179, 2397–2408 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Horiike M. et al. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. Virology 423, 107–118 (2012).
  Article CAS PubMed Google Scholar
• Bourry, O. et al. Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion. Retrovirology 7, 78 (2010).
  Article PubMed PubMed Central Google Scholar
• North, T. W. et al. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J. Virol. 84, 2913–2922 (2010).
  Article CAS PubMed Google Scholar
• Pillai, S. K. et al. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J. Virol. 79, 1734–1742 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kwara, A. et al. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. Clin. Infect. Dis. 46, 719–725 (2008).
  Article CAS PubMed Google Scholar
• Geginat, J., Sallusto, F. & Lanzavecchia, A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells. J. Exp. Med. 194, 1711–1719 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Clements, J. E. et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J. Infect. Dis. 186, 905–913 (2002).
  Article CAS PubMed Google Scholar
• Zeng, M. et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J. Clin. Invest. 121, 998–1008 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med. 12, 1365–1371 (2006).
  Article CAS PubMed Google Scholar
• Hunt, P. W. et al. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J. Infect. Dis. 203, 1474–1483 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chun T. W. et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J. Clin. Invest. 115, 3250–3255 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Deeks, S. G. HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 62, 141–155 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Shan, L. et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491–501 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hocqueloux, L. et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS 24, 1598–1601 (2010).
  Article PubMed Google Scholar
• Hansen, S. G. et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523–527 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hilldorfer, B. B., Cillo, A. R., Besson, G. J., Bedison, M. A. & Mellors, J. W. New tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyond. Curr. HIV/AIDS Rep. 9, 91–100 (2012).
  Article PubMed PubMed Central Google Scholar
• Lewin, S. R. & Rouzioux, C. HIV cure and eradication: how will we get from the laboratory to effective clinical trials? AIDS 25, 885–897 (2011).
  Article PubMed Google Scholar
• Kieffer, T. L. et al. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J. Infect. Dis. 189, 1452–1465 (2004).
  Article CAS PubMed Google Scholar
• Dinoso, J. B. et al. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA 106, 9403–9408 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gandhi, R. T. et al. The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS Med. 7, e1000321 (2010).
  Article PubMed PubMed Central Google Scholar
• Hatano, H. et al. A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J. Infect. Dis. 203, 960–968 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sigal, A. et al. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 477, 95–98 (2011).
  Article CAS PubMed Google Scholar
• Buzon, M. J. et al. Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLoS Pathog. 7, e1002314 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Said, E. A. et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nature Med. 16, 452–459 (2010).
  Article CAS PubMed Google Scholar
• Sharova, N., Swingler, C., Sharkey, M. & Stevenson, M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 24, 2481–2489 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Topalian S. L et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443–2454 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Porter, D. L., Levine, B. L., Kalos, M., Bagg, A. & June, C. H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725–733 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Brooks, D. G. et al. Molecular characterization, reactivation, and depletion of latent HIV. Immunity 19, 413–423 (2003).
  Article CAS PubMed Google Scholar
• Berger, E. A., Moss, B. & Pastan, I. Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART. Proc. Natl Acad. Sci. USA 95, 11511–11513 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Garcia, F. et al. A therapeutic dendritic cell-based vaccine for HIV-1 infection. J. Infect. Dis. 203, 473–478 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275–1286 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Levy, Y. et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J. Clin. Invest. 119, 997–1007 (2009).
  CAS PubMed PubMed Central Google Scholar
• Yang, H. C. et al. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J. Clin. Invest. 119, 3473–3486 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cameron, P. U. et al. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc. Natl Acad. Sci. USA 107, 16934–16939 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Denton, P. W. et al. Generation of HIV latency in humanized BLT mice. J. Virol. 86, 630–634 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hutter, G. et al. Long-term control of HIV by CCR5 delta32/delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692–698 (2009).
  Article PubMed Google Scholar
• Allers, K. et al. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood 117, 2791–2799 (2011).
  Article CAS PubMed Google Scholar
• Ananworanich, J. et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS ONE 7, e33948 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Archin, N. M. et al. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc. Natl Acad. Sci. USA 109, 9523–9528 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Holt N et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nature Biotech. 28, 839–847 (2010).
  Article CAS Google Scholar
• DiGiusto, D. L. et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34+ cells in patients undergoing transplantation for AIDS-related lymphoma. Sci. Transl. Med. 2, 36ra43 (2010).
  Article PubMed PubMed Central Google Scholar